Amino Innovations Develops Next-Generation Peptide Patch Platform to Redefine Everyday Wellness
Pangea Natural Foods (OTC: PNGAF) announced that its subsidiary Amino Innovations developed a next-generation, needle-free peptide patch platform designed for transdermal delivery with bio-dissolving lattice technology. The company says the patches provide one-to-one equivalence to injectable dosing, are shelf-stable up to six months, TSA-friendly, manufactured in a cGMP facility in the United States, and undergo third-party testing. Initial launch includes two formulations: the Wolverine Stack Patch (BPC-157 + TB4) and a TA-1 immune-support patch. Further updates are expected in Q4 2025.
Pangea Natural Foods (OTC: PNGAF) annuncia che la sua controllata Amino Innovations ha sviluppato una piattaforma di patch peptidici all'avanguardia, senza aghi, progettata per somministrazione transdermica con tecnologia a reticolo auto-dissolvente. L'azienda afferma che i patch forniscano un'equivalenza one-to-one con il dosaggio iniettabile, sono stabili in scaffale fino a sei mesi, compatibili con TSA, fabbricati in una struttura cGMP negli Stati Uniti e sottoposti a test da terzi. Il lancio iniziale include due formulazioni: la Wolverine Stack Patch (BPC-157 + TB4) e una patch immunitaria TA-1. Ulteriori aggiornamenti sono previsti nel Q4 2025.
Pangea Natural Foods (OTC: PNGAF) anunció que su subsidiaria Amino Innovations desarrolló una plataforma de parches peptídicos de próxima generación, sin agujas, diseñada para administración transdérmica con tecnología de entramado auto-disolvente. La compañía afirma que los parches proporcionan una equivalencia uno a uno con la dosificación injectada, son estables en estantería hasta seis meses, compatibles con TSA, fabricados en una instalación cGMP en Estados Unidos y sometidos a pruebas de terceros. El lanzamiento inicial incluye dos formulaciones: el Wolverine Stack Patch (BPC-157 + TB4) y un parche de apoyo inmunológico TA-1. Se esperan más actualizaciones en Q4 2025.
Pangea Natural Foods (OTC: PNGAF) 은 자회사 Amino Innovations 가 바늘 없는 차세대 펩타이드 패치 플랫폼을 개발했다고 발표했습니다. 이는 바이오 용해 격자 기술을 이용한 경피 전달을 위한 플랫폼입니다. 회사는 이 패치가 주사 용량과 일대일 등가를 제공하고, 6개월까지 재고 보관 가능하며 TSA 친화적이고, 미국 내 cGMP 시설에서 제조되며 제3자 시험을 거친다고 말합니다. 초기 출시는 두 가지 제형으로 구성됩니다: Wolverine Stack Patch (BPC-157 + TB4)와 TA-1 면역지원 패치입니다. 추가 업데이트는 2025년 Q4에 예정되어 있습니다.
Pangea Natural Foods (OTC: PNGAF) a annoncé que sa filiale Amino Innovations a développé une plateforme de patchs peptidiques de nouvelle génération, sans aiguilles, conçue pour une administration transdermique avec une technologie de maillage bio-dissolvant. La société affirme que les patchs offrent une équivalence un pour un par rapport à la posologie injectable, restent stables en rayon jusqu'à six mois, compatibles TSA, fabriqués dans une installation cGMP aux États-Unis et soumis à des tests par des tiers. Le lancement initial comprend deux formulations : le Wolverine Stack Patch (BPC-157 + TB4) et un patch de soutien immunitaire TA-1. D'autres mises à jour sont prévues au cours du Q4 2025.
Pangea Natural Foods (OTC: PNGAF) gab bekannt, dass seine Tochtergesellschaft Amino Innovations eine Patch-Plattform auf Peptidbasis der nächsten Generation entwickelt hat, ein nadelfreies Design für transdermale Abgabe mit biogitter-/biologischer Gittertechnologie. Die Patchs bieten eine Ein-zu-Eins-Äquivalenz zur injizierbaren Dosierung, sind bis zu sechs Monaten haltbar, TSA-freundlich, hergestellt in einer cGMP-Anlage in den USA und unterliegen Drittanbieter-Tests. Der anfängliche Markteintritt umfasst zwei Formulierungen: den Wolverine Stack Patch (BPC-157 + TB4) und einen TA-1-Immununterstützungs-Patch. Weitere Updates werden voraussichtlich im Q4 2025 erwartet.
أعلنت شركة Pangea Natural Foods (OTC: PNGAF) أن شركتها الفرعية Amino Innovations قامت بتطوير منصة لصاقات ببتيدية من الجيل التالي بدون إبر مصممة للإيصال عبر الجلد باستخدام تقنية الشبكة الحيوية التي تذوب ذاتياً. تقول الشركة إن اللصاقات توفر تعادلاً واحداً مقابل واحد مع الجرعات القابلة للحقن، وتظل صالحة للاستخدام حتى ستة أشهر، ومتوافقة مع TSA، ومصنعة في منشأة cGMP في الولايات المتحدة، وتخضع لاختبارات من طرف ثالث. الإطلاق الأول يتضمن تركيبين: لصاقة Wolverine Stack Patch (BPC-157 + TB4) ولصاقة TA-1 لدعم المناعة. من المتوقع الوصول إلى تحديثات إضافية في الربع الرابع من 2025.
Pangea Natural Foods (OTC: PNGAF) 宣布其子公司 Amino Innovations 已开发出下一代、无针的肽贴片平台，采用生物溶解格子技术进行经皮给药。公司表示这些贴片与注射剂量等效，保质期可达 六个月，符合 TSA 要求，在美国的一家 cGMP 设施生产并经过第三方测试。初始上市包括两种配方：Wolverine Stack Patch（BPC-157 + TB4）和一个 TA-1 免疫支持贴片。预计在 2025 年第四季度有进一步更新。
- None.
- None.
The Amino Innovations Patch utilizes bio-dissolving lattice technology that delivers peptides effectively through the skin's surface layers for rapid and efficient absorption without pain, mixing, or needles. The proprietary design achieves one-to-one equivalence to traditional injectable dosing, eliminating the need for reconstitution, sterile handling, and dosing measurement. Amino Innovations ' Patches are compact, TSA-friendly, shelf-stable for up to six months, and enable consistent peptide delivery for active individuals, travelers, and longevity enthusiasts seeking advanced recovery and wellness support.
Developed in
The Company's initial launch will include two formulations designed to advance recovery and immune optimization. The first formulation, known as the "Wolverine Stack Patch," combines BPC-157 and Thymosin Beta 4 (TB4), two naturally occurring peptides recognized for supporting healing, muscle recovery, tissue regeneration, and overall physical resilience. Alongside this, Amino Innovations plans to introduce the TA-1 patch, formulated to help promote immune balance and strengthen the body's natural defense systems.
Mr. Justin Kirkland, CSO and Co-Founder of Amino Innovations, commented, "These new formulations represent a significant step forward in our mission to make advanced peptide science accessible and effortless. We are focused on bringing innovation, integrity, and accessibility to a category that is quickly evolving from niche to mainstream. These patches are designed to empower individuals to enhance recovery, cellular health, and overall vitality in a simple, convenient, and needle-free format."
The development of Amino Innovations' peptide patch platform represents a major milestone in the continued expansion into the health and wellness sector. The Company remains committed to introducing innovative, evidence-based products that align with its vision of delivering clean and functional wellness solutions for modern consumers.
"The development of this patch technology and its further validation via a third-party study could potentially unlock a breakthrough for the delivery of peptides and expand the total addressable market size in
About Pangea Natural Foods Inc.
Pangea Natural Foods Inc. is a North American manufacturer specializing in clean-label foods and innovative wellness products. Through its subsidiary Amino Innovations, the Company offers advanced, needle-free peptide therapies that support recovery, cognitive function, and overall health.
On Behalf of the Board of Directors
"Pratap Sandhu"
Pratap Sandhu
CEO, Corporate Secretary and Director
+1 (604) 765-8069
Forward-Looking Information
This news release contains forward–looking statements and forward–looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. The forward–looking statements and information are based on certain key expectations and assumptions made by the management of the Company , including Amino Innovation's commercialization of the peptide patches . As a result, there can be no assurance that the acquisition or related matters will be completed as proposed or at all. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward–looking statements and information since no assurance can be given that they will prove to be correct.
Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward–looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the ability of the Company to complete its planned future activities and anticipated business plans. Other factors may also adversely affect the future results or performance of the Company, including general economic, market or business conditions, changes in the financial markets and changes in laws, regulations and policies affecting the Company's operations and the Company's limited operating history. Accordingly, readers should not place undue reliance on the forward–looking statements and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive. The forward– looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward–looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.
Featured Image @ Freepik
Read more investing news on PressReach.com
To subscribe to the PressReach RSS feeds:
- Featured News RSS feed
- Investing News RSS feed
- Daily Press Releases RSS feed
- Trading Tips RSS feed
- Investing Videos RSS feed
To Follow PressReach on Twitter
PressReach on TikTok
PressReach on Instagram
PressReach on YouTube
Contact
Pangea Natural Foods Inc.
Media@pangeafood.com
Photo: https://mma.prnewswire.com/media/2802138/Pangea_Natural_Foods_Inc.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/amino-innovations-develops-next-generation-peptide-patch-platform-to-redefine-everyday-wellness-302590706.html
SOURCE Pangea Natural Foods Inc.
FAQ
What did Pangea (PNGAF) announce on October 21, 2025 about peptide delivery?
What peptides are in the Wolverine Stack Patch from Amino Innovations (PNGAF)?
How long does Pangea claim Amino Innovations' patches remain shelf-stable?
Where are Amino Innovations patches manufactured and tested according to Pangea (PNGAF)?
What is the TA-1 patch that Amino Innovations plans to launch (PNGAF)?
When will Pangea (PNGAF) provide further validation or updates on the peptide patch platform?
